New KRPIA chairman stresses efficient cost of drugs

Published: 2002-08-21 07:00:00

Updated: 2002-08-21 07:00:00

The Korea Research-based Pharmaceutical Industry Association (KRPIA) plans to rectify the public's negative reactions on high-priced drugs, while highlighting the notion that foreign-invested pharmaceutical firms in Korea are centered about R&D oriented new drugs.

Newly appointed KRPIA chairman Jan Peterseemphasized that as far as drug pricing is concerned, the first priority should be place...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.